Events & presentations
Upcoming events
-
Goldman Sachs Global Healthcare Conference 2026 (Miami)
Fireside chat with Adam Steensberg
Past events
-
Jefferies Global Healthcare Conference 2026 (New York)
-
Q1 Financial Results / Interim Report First Quarter 2026
-
Barclays 28th Annual Global Healthcare Conference (Miami)
-
Zealand Pharma topline results from Phase 2 ZUPREME-1 trial for petrelintide
-
Q4 Financial Results / Annual Report 2025
-
J.P. Morgan Healthcare Conference (San Francisco)
-
Capital Markets Day 2025
-
Jefferies Global Healthcare Conference (London)
-
Zealand Pharma Interim Report Q3 2025
-
Bank of America 2025 Global Healthcare Conference (London)
-
Cantor Global Healthcare Conference (New York)
-
Zealand Pharma Interim Report H1 2025
-
Goldman Sachs Annual Global Healthcare Conference (Miami)
-
Bank of America Global Healthcare Conference (Las Vegas)
-
Zealand Pharma Interim Report Q1 2025
-
Zealand Pharma conference call on collaboration and license agreement with Roche to co-develop and co-commercialize petrelintide
-
Zealand Pharma Annual Report 2024
-
Zealand Pharma Interim Report Q3 2024
-
Zealand Pharma Interim Report H1 2024
-
Zealand Pharma topline results for Phase 1b trial of petrelintide
-
Zealand Pharma Interim Report Q1 2024
-
Zealand Pharma Annual Report 2023
-
Zealand Pharma’s Obesity R&D Event
-
Zealand Pharma Interim Report Q3 2023
-
Zealand Pharma Interim Report H1 2023
-
Zealand Pharma Interim Report Q1 2023
-
Zealand Pharma Annual Report 2022
-
Zealand Pharma Interim Report Q3 2022
-
Zealand Pharma Interim Report H1 2022
-
Zealand Pharma Interim Report Q1 2022
-
Zealand Pharma Corporate Update Conference Call
-
Zealand Pharma Annual Report 2021
An overview of Zealand Pharma
CORPORATE PRESENTATION
This presentation is intended for shareholders and investors.
Any information concerning pharmaceuticals (including compounds under development) contained within these materials is not intended as advertising or medical advice.
